FY20 Results and Strategy Overview

Private large portfolio companies EXTERNALLY VALUED e RETAIL (PHARMACY) BUSINESS OVERVIEW Country's largest retailer in terms of both, revenue and number of bills issued BUSINESSES MAJOR GROWTH DRIVERS GHG in pharma PSP Market share by revenue, 20181 Aversi 305 Other 338 519 32% 460 28% 19% 21% Operates under two pharmacy brands, each with a distinct positioning: > GPC for the high-end customer segment > Pharmadepot for the mass retail segment 309 Pharmacies countrywide 309 32 23 9 Shopping Areas 206 115 124 57 38 91 103 67 35 24 3 Clinic Residential area High street Total GPC Pharmadepot > Expending retail footprint › Enhancing retail margin (private label products) > New retail categories such as lab service and beauty GEORGIA CAPITAL > Growing wholesale revenue (such as hospital supplies) > Digital channels Georgia Capital PLC | 1. Total market size 2018 - Frost & Sullivan analysis, revenue distribution between competitors represents managements estimates. Medium to long-term targets ☐ Double digit revenue CAGR Π 9%+ EBITDA margin 49

View entire presentation